Stillwater, OK, United States of America

Lyle W Spruce

This inventor holds 2 USPTO granted patents. Top assignee: Board of Regents for the Oklahoma Agricultural & Mechanical Colleges. Active years: 1989-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lyle W Spruce. Retrieved from https://idiyas.com/inventor/lyle-w-spruce-kmnyefnc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1989-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lyle W. Spruce: Innovator in Anticancer Research

Introduction

Lyle W. Spruce is a notable inventor based in Stillwater, OK (US). He has made significant contributions to the field of anticancer research, holding a total of 2 patents. His work focuses on novel compositions that exhibit potential as anticancer agents.

Latest Patents

Lyle W. Spruce's latest patents include innovative heteroarotinoid compositions characterized by specific chemical formulae. These compositions are designed to exhibit activity as anticancer agents, showcasing the potential for new therapeutic options in cancer treatment. The detailed formulae include variations where X can be S or O, and R can be --H, --OH, --OCH.sub.3, or --OC.sub.2 H.sub.5.

Career Highlights

Lyle W. Spruce is affiliated with the Board of Regents for the Oklahoma Agricultural and Mechanical Colleges. His work in this institution has allowed him to pursue groundbreaking research in the field of medicinal chemistry, particularly in developing new anticancer agents.

Collaborations

Some of Lyle W. Spruce's notable coworkers include Kenneth D. Berlin and Warren T. Ford. Their collaborative efforts contribute to the advancement of research in anticancer therapies.

Conclusion

Lyle W. Spruce's innovative work in developing heteroarotinoid compositions highlights his commitment to advancing cancer treatment options. His contributions to the field are significant and continue to inspire further research in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…